---
title: "Crizotinib - Non-small cell lung cancer"
sidebar: mydoc_sidebar
permalink: db08865-mesh-d002289-1.html
toc: false 
---


Path ID: `DB08865_MESH_D002289_1`
{% include image.html url="images/db08865-mesh-d002289-1.png" file="db08865-mesh-d002289-1.png" alt="db08865-mesh-d002289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C551994 | crizotinib | Drug |
| UniProt:Q9UM73 | anaplastic lymphoma kinase (ALK) | Protein |
| GO:0008283 | proliferation of cells | BiologicalProcess |
| MESH:D002289 | Non-small cell lung cancer | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Crizotinib | DECREASES ACTIVITY OF | Anaplastic Lymphoma Kinase (Alk) |
| Anaplastic Lymphoma Kinase (Alk) | NEGATIVELY REGULATES | Proliferation Of Cells |
| Proliferation Of Cells | CONTRIBUTES TO | Non-Small Cell Lung Cancer |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08865#mechanismofaction](https://go.drugbank.com/drugs/DB08865#mechanismofaction)
